Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in parkinson's disease brain

Brain Pathology

Volumn 21, Issue 2, 2011, Pages 130-139

  Wilhelmus, Micha M M ^a   Verhaar, Robin ^a   Andringa, Gerda ^a,d   Bol, John G J M ^a   Cras, Patrick ^b   Shan, Ling ^c   Hoozemans, Jeroen J M ^a   Drukarch, Benjamin ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d Roosevelt Academy   (Netherlands)

Author keywords

endoplasmic reticulum; neurodegeneration; Parkinson's disease; tissue transglutaminase

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

AGED; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME LOCALIZATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; PARKINSON DISEASE; PROTEIN PHOSPHORYLATION;

AGED; ALPHA-SYNUCLEIN; BRAIN; EIF-2 KINASE; ENDOPLASMIC RETICULUM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEURONS; PARKINSON DISEASE; TRANSGLUTAMINASES;

EID: 79251589371     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2010.00429.x     Document Type: Article

References (56)

1. Andringa G, Lam KY, Chegary M, Wang X, Chase TN, Bennett MC, (2004) Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson's disease. FASEB J 18: 932-934.
2. Beck KE, De Girolamo LA, Griffin M, Billett EE, (2006) The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells. Neurosci Lett 11: 46-51.
3. Bedard K, Szabo E, Michalak M, Opas M, (2005) Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57. Int Rev Cytol 245: 91-121.
4. Blanchard N, Shastri N, (2008) Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol 20: 82-88.
5. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E, (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211.
6. Colla E, Liu Y, Stirling W, Jensen PH, Iwatsubo T, Lee MK, (2009) Endoplasmic reticulum stress and mircosomes aggretated alpha-synuclein are associated with the alpha-synucleinopathies in vivo. Neuroscience Meeting, San Diego, CA: Society for Neuroscience, 532.11/K10.
7. Duda JE, Lee VM, Trojanowski JQ, (2000) Neuropathology of synuclein aggregates. J Neurosci Res 61: 121-127.
8. Evdonin AL, Martynova MG, Bystrova OA, Guzhova IV, Margulis BA, Medvedeva ND, (2006) The release of Hsp70 from A431 carcinoma cells is mediated by secretory-like granules. Eur J Cell Biol 85: 443-455.
9. Feng JF, Readon M, Yadav SP, Im MJ, (1999) Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry 38: 10743-10749.
10. Fesus L, (1993) Biochemical events in naturally occurring forms of cell death. FEBS Lett 328: 1-5.
11. Fesus L, Piacentini M, (2002) Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem Sci 27: 534-539.
12. Fesus L, Horvath A, Harsfalvi J, (1983) Interaction between tissue transglutaminase and phospholipid vesicles. FEBS Lett 155: 1-5.
13. Gentile V, Sepe C, Calvani M, Melone MA, Cotrufo R, Cooper AJ, et al (1998) Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch Biochem Biophys 352: 314-321.
14. Halverson RA, Lewis J, Frausto S, Hutton M, Muma NA, (2005) Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice. J Neurosci 25: 1226-1233.
15. Hand D, Campoy FJ, Clark S, Fisher A, Haynes LW, (1993) Activity and distribution of tissue transglutaminase in association with nerve-muscle synapses. J Neurochem 61: 1064-1072.
16. Harsfalvi J, Arato G, Fesus L, (1987) Lipids associated with tissue transglutaminase. Biochim Biophys Acta 923: 42-45.
17. Hartley DM, Zhao C, Speier AC, Woodard GA, Li S, Li Z, et al (2008) Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation. J Biol Chem 283: 16790-16800.
18. Hegmans JP, Bard MP, Hemmes A, Luider TM, Kleijmeer MJ, Prins JB, et al (2004) Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol 164: 1807-1815. (Pubitemid 38529783)
19. Holtz WA, O'Malley KL, (2003) Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons. J Biol Chem 278: 19367-19377.
20. Hoozemans JJ, van Haastert ES, Eikelenboom P, de Vos RA, Rozemuller JM, Scheper W, (2007) Activation of the unfolded protein response in Parkinson's disease. Biochem Biophys Res Commun 354: 707-711.
21. Ientile R, Caccamo D, Griffin M, (2007) Tissue transglutaminase and the stress response. Amino Acids 33: 385-394.
22. Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM, (2003) Tissue transglutaminase-induced aggregation of alpha-synuclein: implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 100: 2047-2052.
23. Kahlem P, Green H, Djian P, (1998) Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol Cell 1: 595-601.
24. Kamhi-Nesher S, Shenkman M, Tolchinsky S, Fromm SV, Ehrlich R, Lederkremer GZ, (2001) A novel quality control compartment derived from the endoplasmic reticulum. Mol Biol Cell 12: 1711-1723.
25. Karpuj MV, Becher MW, Steinman L, (2002) Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications. Neurochem Int 40: 31-36.
26. Kim-Han JS, O'Malley KL, (2007) Cell stress induced by the Parkinsonian mimetic, 6-hydroxydopamine, is concurrent with oxidation of the chaperone, ERp57, and aggresome formation. Antioxid Redox Signal 9: 2255-2264.
27. Lai TS, Tucker T, Burke JR, Strittmatter WJ, Greenberg CS, (2004) Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. J Neurochem 88: 1253-1260.
28. Lee YM, Park SH, Chung KC, Oh YJ, (2003) Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxydopamine. Neurosci Lett 352: 17-20.
29. Lesort M, Chun W, Johnson GV, Ferrante RJ, (1999) Tissue transglutaminase is increased in Huntington's disease brain. J Neurochem 73: 2018-2027.
30. Li Z, Srivastava P, (2004) Heat-shock proteins. Curr Protoc Immunol; Appendix 1: Appendix 1T. Review.
31. Lorand L, Graham RM, (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4: 140-156.
32. Martinez A, Portero-Otin M, Pamplona R, Ferrer I, (2010) Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 20: 281-297.
33. Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi E, Gentile V, Davies PJ, et al (1994) Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 14: 6584-6596.
34. Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M, (2009) Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 417: 651-666.
35. Miller ML, Johnson GV, (1995) Transglutaminase cross-linking of the tau protein. J Neurochem 65: 1760-1770.
36. Nemes Z, Petrovski G, Aerts M, Seargent K, Devreese B, Fesus L, (2009) Transglutaminase-mediated intramolecular cross-linking of membrane-bound {alpha}-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem 40: 27252-27264.
37. Ni M, Lee AS, (2007) ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641-3651.
38. Norlund MA, Lee JM, Zainelli GM, Muma NA, (1999) Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease. Brain Res 851: 154-163.
39. Orru S, Caputo I, D'Amato A, Ruoppolo M, Esposito C, (2003) Proteomics identification of acyl-acceptor and acyl-donor substrates for transglutaminase in a human intestinal epithelial cell line. Implications for celiac disease. J Biol Chem 278: 31766-31773.
40. Park D, Choi SS, Ha KS, (2010) Transglutaminase 2: a multi-functional protein in multiple subcellular compartments. Amino Acids; doi 10.1007/s00726-010-0500-z [E-pub ahead of print].
41. Rodolfo C, Mormone E, Matarrese P, Ciccosanti F, Farrace MG, Garofano E, et al (2004) Tissue transglutaminase is a multifunctional BH3-only protein. J Biol Chem 279: 54783-54792.
42. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J, (2009) ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. J Neuroinflammation 6: 41.
43. Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD, (1990) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54: 823-827.
44. Schmid AW, Chiappe D, Pignat V, Grimminger V, Hang I, Moniatte M, et al (2009) Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease. J Biol Chem 284: 13128-13142.
45. Segers-Nolten I, Wilhelmus MM, Veldhuis G, van RB, Drukarch B, Subramaniam V, (2008) Tissue transglutaminase modulates {alpha}-synuclein oligomerization. Protein Sci 17: 1395-1402.
46. Singer SM, Zainelli GM, Norlund MA, Lee JM, Muma NA, (2002) Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease. Neurochem Int 40: 17-30.
47. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME, (1998) Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21: 516-520.
48. Wang HQ, Takahashi R, (2007) Expanding insights on the involvement of endoplasmic reticulum stress in Parkinson's disease. Antioxid Redox Signal 9: 553-561.
49. Wang J, Mayernik L, Armant DR, (2002) Integrin signaling regulates blastocyst adhesion to fibronectin at implantation: intracellular calcium transients and vesicle trafficking in primary trophoblast cells. Dev Biol 245: 270-279.
50. Wilhelmus MM, Grunberg SC, Bol JG, van Dam AM, Hoozemans JJ, Rozemuller AJ, et al (2008) Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer's disease brain. Brain Pathol 19: 612-622.
51. Wilhelmus MM, van Dam AM, Drukarch B, (2008) Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol 585: 464-472.
52. Wilhelmus MM, Verhaar R, Bol JG, van Dam AM, Hoozemans JJ, Rozemuller AJ, et al (2009) Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol Aging; doi.org/10.1016/j.neurobiolaging.2009.04.019 [E-pub ahead of print].
53. Winklhofer KF, Haass C, (2010) Mitochondrial dysfunction in Parkinson's disease. Biochim Biophys Acta 1802: 29-44.
54. Xiao G, Chung TF, Pyun HY, Fine RE, Johnson RJ, (1999) KDEL proteins are found on the surface of NG108-15 cells. Brain Res Mol Brain Res 72: 121-128.
55. Zainelli GM, Ross CA, Troncoso JC, Muma NA, (2003) Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J Neuropathol Exp Neurol 62: 14-24.
56. Zemskov EA, Mikhailenko I, Strickland DK, Belkin AM, (2007) Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1. J Cell Sci 120: 3188-3199.